deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02616666

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE)

A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients (DECIDE Study)

Sponsor: AstraZeneca

Conditions Type 2 Diabetes Mellitus
Interventions Dapagliflozin Standard of Care
Updated 28 times since 2017 Last updated: Feb 17, 2026 Started: Aug 25, 2016 Primary completion: Dec 12, 2025 Completion: Dec 12, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Type 2 Diabetes Mellitus and is currently completed. AstraZeneca leads this study, which shows 28 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~May 2017 · 30 days · monthly snapshot~May 2017 – ~Jun 2017 · 31 days · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Dec 2017 · 5 months · monthly snapshot~Dec 2017 – ~Jan 2018 · 31 days · monthly snapshot~Jan 2018 – ~Mar 2018 · 59 days · monthly snapshot~Mar 2018 – ~Apr 2018 · 31 days · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Nov 2018 · 4 months · monthly snapshot~Nov 2018 – ~Feb 2019 · 3 months · monthly snapshot~Feb 2019 – ~Feb 2020 · 12 months · monthly snapshot~Feb 2020 – ~Jun 2020 · 4 months · monthly snapshot~Jun 2020 – ~Sep 2020 · 3 months · monthly snapshot~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Jun 2022 · 17 months · monthly snapshot~Jun 2022 – ~Jun 2023 · 12 months · monthly snapshot~Jun 2023 – ~Jan 2024 · 7 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Sep 2025 · 8 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 7 months · monthly snapshot

Change History

28 versions recorded

  1. Feb 2026 — Present [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  2. Sep 2025 — Feb 2026 [monthly]

    Active Not Recruiting PHASE4

  3. Jan 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE4

  4. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

▶ Show 23 earlier versions

  1. Jan 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

  2. Jun 2023 — Jan 2024 [monthly]

    Active Not Recruiting PHASE4

  3. Jun 2022 — Jun 2023 [monthly]

    Active Not Recruiting PHASE4

  4. Jan 2021 — Jun 2022 [monthly]

    Active Not Recruiting PHASE4

  5. Nov 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

  6. Sep 2020 — Nov 2020 [monthly]

    Active Not Recruiting PHASE4

  7. Jun 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  8. Feb 2020 — Jun 2020 [monthly]

    Recruiting PHASE4

  9. Feb 2019 — Feb 2020 [monthly]

    Recruiting PHASE4

  10. Nov 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  11. Jul 2018 — Nov 2018 [monthly]

    Recruiting PHASE4

  12. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE4

  13. May 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  14. Apr 2018 — May 2018 [monthly]

    Recruiting PHASE4

  15. Mar 2018 — Apr 2018 [monthly]

    Recruiting PHASE4

  16. Jan 2018 — Mar 2018 [monthly]

    Recruiting PHASE4

  17. Dec 2017 — Jan 2018 [monthly]

    Recruiting PHASE4

  18. Jul 2017 — Dec 2017 [monthly]

    Recruiting PHASE4

  19. Jun 2017 — Jul 2017 [monthly]

    Recruiting PHASE4

  20. May 2017 — Jun 2017 [monthly]

    Recruiting PHASE4

  21. Apr 2017 — May 2017 [monthly]

    Recruiting PHASE4

  22. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE4

  23. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AstraZeneca
  • Clinical Practice Research Datalink
  • University of Liverpool
Data source: University of Liverpool

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Alcester, United Kingdom , Alton, United Kingdom , Altrincham, United Kingdom , Atherstone, United Kingdom , Axbridge, United Kingdom , Ayr, United Kingdom , Balham, United Kingdom , Barnoldswick, United Kingdom , Barry, United Kingdom , Beckenham, United Kingdom and 103 more locations